Expert Review of Hematology

Papers
(The H4-Index of Expert Review of Hematology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
D-dimer level in COVID-19 infection: a systematic review224
Genetic risk factors for venous thromboembolism45
Evidence-based indications of platelet-rich plasma therapy41
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures37
Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd32
A review of FDA-approved acute myeloid leukemia therapies beyond ‘7 + 3’29
Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia27
COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis23
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians23
Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits22
The biology and management of dyskeratosis congenita and related disorders of telomeres21
Complement activation and coagulopathy - an ominous duo in COVID1920
Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape20
Pacritinib for the treatment of patients with myelofibrosis and thrombocytopenia20
Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma19
Platelets: the point of interconnection among cancer, inflammation and cardiovascular diseases18
Monoclonal antibodies in relapsed/refractory myeloma: updated evidence from clinical trials, real-life studies, and meta-analyses18
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis18
0.098198175430298